| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/03/2011 | CN101791378B Traditional Chinese medicine preparation for wound hemostasis, anti-inflammatory and tissue regeneration |
| 08/03/2011 | CN101683468B Medicament for treating burns and scalds and preparation method thereof |
| 08/03/2011 | CN101658583B Traditional Chinese medicine for treating cold-dampness type skin ulcer and preparation method thereof |
| 08/03/2011 | CN101618019B Triamcinolone acetonide acetate particle, and preparation method and medicinal composition thereof |
| 08/03/2011 | CN101590077B Compound erythromycin zinc acetate ointment for local use |
| 08/03/2011 | CN101548983B Skin disinfectant and method of producing the same |
| 08/03/2011 | CN101461850B Application of Chinese medicinal composition in preparing medicament for treating acne |
| 08/03/2011 | CN101391047B Traditional Chinese medicine preparation for treating trichonosis |
| 08/03/2011 | CN101327168B Method for extracting sea mud active component |
| 08/03/2011 | CN101095810B Decoction medicine for treating seborrhoeic dermatitis and method for preparing the same |
| 08/03/2011 | CN101054418B Fusion polypeptide and application thereof in preparing scald medicament |
| 08/02/2011 | US7989661 Human ADAM-10 inhibitors |
| 08/02/2011 | US7989602 Synthetic molecules having immune activity |
| 08/02/2011 | US7989478 Cinnamoyl compound and use of the same |
| 08/02/2011 | CA2668311C Enhancing photodamage caused by ultraviolet light using a 3-hydroxypyridine analog |
| 08/02/2011 | CA2625806C Compositions for improving skin conditions comprising human growth hormone as an active ingredient |
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 08/02/2011 | CA2447010C Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2011 | CA2427964C Method and preparations having effect against allergic symptoms |
| 08/02/2011 | CA2418976C Skin wound healing promoters |
| 08/02/2011 | CA2417984C Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 08/02/2011 | CA2395593C Azaindoles |
| 08/02/2011 | CA2328418C Use of lipopeptides or lipoproteins for wound treatment |
| 07/28/2011 | WO2011091244A1 Methods to treat or prevent a skin condition using a nell1 peptide |
| 07/28/2011 | WO2011091084A2 Stabilized proteases for use in skin care |
| 07/28/2011 | WO2011090926A1 Nutritional formulas containing synbiotics |
| 07/28/2011 | WO2011090741A2 TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63 |
| 07/28/2011 | WO2011090062A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | WO2011089173A1 Hydrogel of microspheres |
| 07/28/2011 | WO2011089161A1 Pharmaceutical compositions comprising lignans and their derivatives for the medical management of angiogenesis and hypovascularity |
| 07/28/2011 | WO2008089243A3 The redox/fyn/c-cbl pathway |
| 07/28/2011 | US20110185439 G protein coupled receptors and uses thereof |
| 07/28/2011 | US20110184220 Methods for the treatment of radiation or chemotherapy-induced tissue damage |
| 07/28/2011 | US20110184060 Oral dosage forms having a high loading of a tranexamic acid prodrug |
| 07/28/2011 | US20110184038 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184032 Novel Phenylamino Isonicotinamide Compounds |
| 07/28/2011 | US20110184022 Organic Compounds |
| 07/28/2011 | US20110184020 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions |
| 07/28/2011 | US20110184016 Prevention and treatment of itch with cysteine protease inhibition |
| 07/28/2011 | US20110184015 Novel derivatives of pyrroloindole which are inhibitors of hsp90, compositions containing same, and use thereof |
| 07/28/2011 | US20110184011 Compounds |
| 07/28/2011 | US20110184001 Inhibitors of bruton's tyrosine kinase |
| 07/28/2011 | US20110183997 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/28/2011 | US20110183986 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/28/2011 | US20110183985 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
| 07/28/2011 | US20110183983 Heterocyclic compound as protein kinase inhibitor |
| 07/28/2011 | US20110183966 Aminopyridine kinase inhibitors |
| 07/28/2011 | US20110183965 6-aminoisoquinoline compounds |
| 07/28/2011 | US20110183948 Treatment of fibrotic conditions using hedgehog inhibitors |
| 07/28/2011 | US20110183943 Concurrent therapy regime/regimen for the treatment of acne related diseases |
| 07/28/2011 | US20110183908 Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions |
| 07/28/2011 | US20110183890 Methods for modulating angiogenesis via dystrophin dp71 |
| 07/28/2011 | US20110183886 Melanocortin receptor ligands |
| 07/28/2011 | US20110183016 Film-forming liquid formulations for drug release to hair and scalp |
| 07/28/2011 | US20110183011 Composition and method for topical treatment of skin lesions |
| 07/28/2011 | US20110183001 Compositions and methods for implantation of adipose tissue and adipose tissue products |
| 07/28/2011 | US20110182999 Ceramide dispersion and method for producing same |
| 07/28/2011 | US20110182991 Method for improved fibrin sealing |
| 07/28/2011 | US20110182989 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites |
| 07/28/2011 | US20110182957 Cellulosics for tissue replacement |
| 07/28/2011 | US20110182913 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 07/28/2011 | US20110182905 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 07/28/2011 | US20110182895 Antibody variants |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |
| 07/28/2011 | US20110182889 Compositions and methods for the treatment of natural killer cell related diseases |
| 07/28/2011 | US20110182885 Formulations and treatments for well-being |
| 07/28/2011 | US20110182861 Cosmetic use of microorganisms for the treatment of oily skin |
| 07/28/2011 | US20110182828 C20-c21 substituted glucocorticoid receptor agonists |
| 07/28/2011 | CA2787248A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | CA2786866A1 Hydrogel of microspheres |
| 07/28/2011 | CA2785177A1 Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63 |
| 07/27/2011 | EP2348048A1 Antagonistic Anti-HTNFSF13B Human Antibodies |
| 07/27/2011 | EP2348023A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/27/2011 | EP2347793A1 Method for regenerating hair follicles by suppressing a gene with hair follicle formation-inhibiting ability or by activating a gene with hair follicle formation - inducing ability |
| 07/27/2011 | EP2347771A1 Peptide-based compounds for targeted imaging |
| 07/27/2011 | EP2346867A1 Phosphodiestarase inhibitors |
| 07/27/2011 | EP2346827A1 Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors |
| 07/27/2011 | EP2346819A1 Naphthylacetic acids |
| 07/27/2011 | EP2346573A2 Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations |
| 07/27/2011 | EP2346526A2 Compositions of and methods of using ligand dimers |
| 07/27/2011 | EP2346514A1 Medium derived from stem cells as a pharmaceutical composition |
| 07/27/2011 | EP2346512A1 Composition for prevention and treatment of allergic and/or inflammatory diseases |
| 07/27/2011 | EP1992622B1 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
| 07/27/2011 | EP1878738B1 1-kestose for treating allergy and atopic dermatitis |
| 07/27/2011 | EP1744746B1 Use of melatonin in preventing postoperative complications |
| 07/27/2011 | EP1638964B1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/27/2011 | EP1389616B1 3,4-Dihalobenzylpiperidine derivatives and their medical use |
| 07/27/2011 | EP1351694B2 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 07/27/2011 | EP1312360B1 Analgesic/antiinflammatory patches for topical use |
| 07/27/2011 | CN1984899B CXCR1 and CXCR2 chemokine antagonists |
| 07/27/2011 | CN1968708B Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency |
| 07/27/2011 | CN1393222B Use of composition of sterol compounds dissolved in oil |
| 07/27/2011 | CN1309666B Polymer composition of glucuronic acid glucosan |
| 07/27/2011 | CN102137863A Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/27/2011 | CN102137862A Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/27/2011 | CN102137839A Use of an N-acyl amino acid selected from among N-palmitoyl alanine, N-palmitoyl glycine, and N-palmitoyl isoleucine as a regulating active agent of the genetic profile of senescent replicating fibroblasts of the human skin dermis |
| 07/27/2011 | CN102137673A Steroidal compounds as melanogenesis modifiers and uses thereof |
| 07/27/2011 | CN102137664A Pharmaceutical solid preparation having active ingredients separated by boundary therein |
| 07/27/2011 | CN102137663A Stable pharmaceutical formulation with limited discoloration |